sanofi lowers EPS guidance

sanofi-aventis Group (Euronext:SAN; NYSE:SNY) lowered its 2010 EPS guidance on Friday after FDA approved a generic version of the company's marketed anticoagulant Lovenox enoxaparin. sanofi now expect...